U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07313059) titled 'CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research' on Nov. 26, 2025.
Brief Summary: People identified to have CH or thought to have possible CH due to unexplained low blood cell counts, including low red blood cells, white blood cells, or platelets will be asked to take part in the study.
Individuals who are confirmed to have CH and provide informed consent to participate in the study will have monitoring of their CH, assessment of the risk of heart diseases, blood cancers and personalised support. The researchers will also measure people's understanding of CH and how they feel after learning about CH.
R...